Martingale Asset Management’s DICE Therapeutics DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-17,987
Closed -$836K – 865
2023
Q2
$836K Sell
17,987
-6,967
-28% -$241K 0.02% 493
2023
Q1
$715K Buy
+24,954
New +$739K 0.01% 530

Martingale Asset Management's DICE Position: Q3 2023 in Review

Martingale Asset Management sold out of DICE Therapeutics (DICE) in Q3 2023, closing a stake of 17,987 shares — an estimated $836K sold.

Martingale Asset Management first reported a position in DICE in Q1 2023 and held it in 2 quarters. The position peaked at $836K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Martingale Asset Management reported no remaining DICE Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Martingale Asset Management sold 17,987 DICE Therapeutics shares in Q3 2023, an estimated $836K.
  • Martingale Asset Management first reported a position in DICE Therapeutics in Q1 2023 and held it in 2 quarters.
  • Martingale Asset Management's DICE Therapeutics position peaked at $836K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics as of Q3 2023.

Based on Martingale Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.